Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Augmentation of specific immune response against a syngeneic SV40-induced sarcoma in mice by depletion of suppressor T cells with cyclophosphamide.

× No keyword cloud information.

24 in total

1. Cancer chemotherapeutics as immunomodulators.

Authors: F Spreafico; A Vecchi; F Colotta; A Montovani
Journal: Springer Semin Immunopathol Date: 1985

2. Increased efficiency of immunotherapy using irradiated tumor cells.

Authors: J M Wu; J Fitzgerald; S Sonis; T Ravikumar; R Wilson
Journal: Cancer Immunol Immunother Date: 1987 Impact factor: 6.968

3. The effects of cyclophosphamide and irradiation singly and in combination upon SaI growth in A/J mice.

Authors: R E Anderson; W L Williams; S Tokuda
Journal: Am J Pathol Date: 1987-05 Impact factor: 4.307

4. Combination chemoimmunotherapy for advanced gastric carcinoma.

Authors: T Akiyoshi; M Kawaguchi; S Arinaga; S Miyazaki; F Koba; T Wada; H Tsuji
Journal: Jpn J Surg Date: 1984-05

5. Improved systemic delivery of oncolytic reovirus to established tumors using preconditioning with cyclophosphamide-mediated Treg modulation and interleukin-2.

Authors: Timothy Kottke; Jill Thompson; Rosa Maria Diaz; Jose Pulido; Candice Willmon; Matt Coffey; Peter Selby; Alan Melcher; Kevin Harrington; Richard G Vile
Journal: Clin Cancer Res Date: 2009-01-15 Impact factor: 12.531

6. Partial CD4 depletion reduces regulatory T cells induced by multiple vaccinations and restores therapeutic efficacy.

Authors: Michael G LaCelle; Shawn M Jensen; Bernard A Fox
Journal: Clin Cancer Res Date: 2009-11-10 Impact factor: 12.531

7. Nonspecific and selective stimulation of the immune system in the treatment of carcinoma in humans.

Authors: R E Falk; L Makowka; U Ambus; J A Falk; R Bugala; S Landi
Journal: Can Med Assoc J Date: 1983-06-15 Impact factor: 8.262

8. Cyclophosphamide promotes pulmonary metastasis on mouse lung adenocarcinoma.

Authors: Shuli Man; Yanjun Zhang; Wenyuan Gao; Lulu Yan; Chaoyi Ma
Journal: Clin Exp Metastasis Date: 2008-09-03 Impact factor: 5.150

9. Inability to mediate prolonged reduction of regulatory T Cells after transfer of autologous CD25-depleted PBMC and interleukin-2 after lymphodepleting chemotherapy.

Authors: Daniel J Powell; Christiaan R de Vries; Tamika Allen; Mojgan Ahmadzadeh; Steven A Rosenberg
Journal: J Immunother Date: 2007 May-Jun Impact factor: 4.456

10. The influence of cyclophosphamide on antitumor immunity in mice bearing late-stage tumors.

Authors: F Culo; I Klapan; T Kolak
Journal: Cancer Immunol Immunother Date: 1993 Impact factor: 6.968